Frost & Sullivan Awards honors European health care

5 March 2007

A range of health care-related firms have been honored at an awards ceremony held in London, UK, ranging from drug discovery technologies to patient monitoring.

Among the drug industry winners, Zug, Switzerland-based biotechnology firm, AmVac AG, was awarded the 2006 Enabling Technology of the Year Award in the Biotherapeutic Drugs and Treatment Procedures Market.

AmVac was launched in 2005 and has two advanced biotherapeutic drugs having the potential to be new gold standard technologies in gynecology and urology, according to the award citation: Femivac for the treatment of bacterial vaginosis and trichomoniasis, and Prostavac for the treatment of benign prostatic hyperplasia and acute or chronic prostatitis. Frost & Sullivan, the health care analysts, hosted the Excellence in Healthcare Awards Banquet on February 21 in London, UK.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >

Today's issue

Company Spotlight

Ironwood is a US-based biotech advancing a pipeline of medicines in multiple areas of significant unmet need, including irritable bowel syndrome with constipation ((IBS-C)/chronic idiopathic constipation (CIC), vascular and fibrotic diseases, and refractory gastroesophageal reflux disease, among others.